3. Boulkroun S, Fernandes-Rosa FL, Zennaro MC. Old and new genes in primary aldosteronism.Best Pract Res Clin Endocrinol Metab. 2020;34:101375
4. Castro-Vega LJ, Calsina B, Burnichon N, Drossart T, Martinez-Montes AM, Verkarre V, Amar L, Bertherat J, Rodriguez-Antona C, Favier J, Robledo M, Gimenez-Roqueplo AP. Overexpression of mir-483-5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma.Clin Transl Med. 2020;10:e260
5. Cavagna P, Stephane Ikama M, Euloge Kramoh K, Laurent Takombe J, Bara Diop I, Ali Toure I, Balde DM, Dzudie A, Ferreira B, Houenassi MD, Hounkponou M, Kane A, Kimbally-Kaki SG, Kingue S, Kouam Kouam C, Limbole E, Mfeukeu Kuate L, Bruno Mipinda J, N’Guetta R, Nhavoto C, Marie Damorou J, Sidy Ali A, Gaye B, Tajeu GS, Macquart de Terline D, Cecile Perier M, Azizi M, Jouven X, Antignac M. Antihypertensive strategies and hypertension control in sub-saharan africa.Eur J Prev Cardiol. 2020:2047487320937492
6. Constantinescu G, Langton K, Conrad C, Amar L, Assie G, Gimenez-Roqueplo AP, Blanchard A, Larsen CK, Mulatero P, Williams TA, Prejbisz A, Fassnacht M, Bornstein S, Ceccato F, Fliedner S, Dennedy M, Peitzsch M, Sinnott R, Januszewicz A, Beuschlein F, Reincke M, Zennaro MC, Eisenhofer G, Deinum J. Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension.J Clin Endocrinol Metab. 2020;105
7. Cornu E, Motiejunaite J, Belmihoub I, Vidal-Petiot E, Mirabel M, Amar L. Acute stress cardiomyopathy: Heart of pheochromocytoma.Ann Endocrinol (Paris). 2020
8. Courand PY, Marques P, Vargas-Poussou R, Azizi M, Blanchard A, investigators Gs.Qt interval in adult with chronic hypokalemia due to gitelman syndrome: Not so frequently prolonged.Clin J Am Soc Nephrol. 2020;15:1640-1642
9. de Freminville JB, Azizi M. [are renin-angiotensin system inhibitors protective or deleterious in patients with covid-19?].Arch Mal Coeur Vaiss Pratique. 2020;2020:20-24
10. De Sousa K, Boulkroun S, Baron S, Nanba K, Wack M, Rainey WE, Rocha A, Giscos-Douriez I, Meatchi T, Amar L, Travers S, Fernandes-Rosa FL, Zennaro MC. Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma.Hypertension. 2020;75:1034-1044
11. Erlic Z, Reel P, Reel S, Amar L, Pecori A, Larsen CK, Tetti M, Pamporaki C, Prehn C, Adamski J, Prejbisz A, Ceccato F, Scaroni C, Kroiss M, Dennedy MC, Deinum J, Langton K, Mulatero P, Reincke M, Lenzini L, Gimenez-Roqueplo AP, Assie G, Blanchard A, Zennaro MC, Jefferson E, Beuschlein F. Targeted metabolomics as a tool in discriminating endocrine from primary hypertension.J Clin Endocrinol Metab. 2020
12. Fernandes-Rosa FL, Boulkroun S, Zennaro MC. Genetic and genomic mechanisms of primary aldosteronism.Trends Mol Med. 2020;26:819-832
13. Fouassier D, Blanchard A, Fayol A, Bobrie G, Boutouyrie P, Azizi M, Hulot JS. Sequential nephron blockade with combined diuretics improves diastolic function in patients with resistant hypertension.ESC Heart Fail. 2020;7:2561-2571
14. Georges A, Albuisson J, Berrandou T, Dupre D, Lorthioir A, D’Escamard V, Di Narzo AF, Kadian-Dodov D, Olin JW, Warchol-Celinska E, Prejbisz A, Januszewicz A, Bruneval P, Baranowska AA, Webb TR, Hamby SE, Samani NJ, Adlam D, Fendrikova-Mahlay N, Hazen S, Wang Y, Yang ML, Hunker K, Combaret N, Motreff P, Chedid A, Fiquet B, Plouin PF, Mousseaux E, Azarine A, Amar L, Azizi M, Gornik HL, Ganesh SK, Kovacic JC, Jeunemaitre X, Bouatia-Naji N. Rare loss-of-function mutations of ptgir are enriched in fibromuscular dysplasia.Cardiovasc Res. 2020
15. Gosse P, Cremer A, Kirtane AJ, Lobo MD, Saxena M, Daemen J, Wang Y, Stegbauer J, Weber MA, Abraham J, Kario K, Bangalore S, Claude L, Liu Y, Azizi M. Ambulatory blood pressure monitoring to predict response to renal denervation: A post hoc analysis of the radiance-htn solo study.Hypertension. 2020:HYPERTENSIONAHA12016292
16. Job S, Georges A, Burnichon N, Buffet A, Amar L, Bertherat J, Bouatia-Naji N, de Reynies A, Drui D, Lussey-Lepoutre C, Favier J, Gimenez-Roqueplo AP, Castro-Vega LJ. Transcriptome analysis of lncrnas in pheochromocytomas and paragangliomas.J Clin Endocrinol Metab. 2020;105
17. Kably B, Billaud EM, Boutouyrie P, Azizi M. Is there any hope for monitoring adherence in an efficient and feasible way for resistant hypertension diagnosis and follow-up?Curr Hypertens Rep. 2020;22:96
18. Kamenicky P, Blanchard A, Lamaziere A, Piedvache C, Donadille B, Duranteau L, Bry H, Gautier JF, Salenave S, Raffin-Sanson ML, Genc S, Pietri L, Christin-Maitre S, Thomas J, Lorthioir A, Azizi M, Chanson P, Le Bouc Y, Brailly-Tabard S, Young J. Cortisol and aldosterone responses to hypoglycemia and na depletion in women with non-classic 21-hydroxylase deficiency.J Clin Endocrinol Metab. 2020;105
19. Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: Implications for covid-19.Cardiovasc Res. 2020;116:1688-1699
20. Lauder L, Azizi M, Kirtane AJ, Bohm M, Mahfoud F. Device-based therapies for arterial hypertension.Nat Rev Cardiol. 2020;17:614-628
21. Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers H, Castinetti F, Dralle H, Widimsky J, Gimenez-Roqueplo AP, Eisenhofer G. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: A position statement and consensus of the working group on endocrine hypertension of the european society of hypertension.J Hypertens. 2020;38:1443-1456
22. Lussey-Lepoutre C, Bellucci A, Burnichon N, Amar L, Buffet A, Drossart T, Fontaine S, Clement O, Benit P, Rustin P, Groussin L, Meatchi T, Gimenez-Roqueplo AP, Tavitian B, Favier J. Succinate detection using in vivo (1)h-mr spectroscopy identifies germline and somatic sdhx mutations in paragangliomas.Eur J Nucl Med Mol Imaging. 2020;47:1510-1517
23. Macquart de Terline D, Kramoh KE, Bara Diop I, Nhavoto C, Balde DM, Ferreira B, Houenassi MD, Hounsou D, Ikama MS, Kane A, Kimbally-Kaki SG, Kingue S, Koffi F, Kouam Kouam C, Limbole E, Mfeukeu Kuate L, Mipinda JB, N’Goran Y, Sesso Z, Sidi Aly A, Toure IA, Plouin PF, Azizi M, Perier MC, Narayanan K, Empana JP, Jouven X, Antignac M. Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-saharan countries.Arch Cardiovasc Dis. 2020;113:433-442
24. Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Bohm M, Burnier M, Chatellier G, Durand Zaleski I, Grassi G, Joner M, Kandzari DE, Kirtane A, Kjeldsen SE, Lobo MD, Luscher TF, McEvoy JW, Parati G, Rossignol P, Ruilope L, Schlaich MP, Shahzad A, Sharif F, Sharp ASP, Sievert H, Volpe M, Weber MA, Schmieder RE, Tsioufis C, Wijns W. Proceedings from the 3rd european clinical consensus conference for clinical trials in device-based hypertension therapies.Eur Heart J. 2020;41:1588-1599
25. Marc Y, Boitard SE, Balavoine F, Azizi M, Llorens-Cortes C. Targeting brain aminopeptidase a: A new strategy for the treatment of hypertension and heart failure.Can J Cardiol. 2020;36:721-731
26. Motiejunaite J, Amar L, Vidal-Petiot E. Adrenergic receptors and cardiovascular effects of catecholamines.Ann Endocrinol (Paris). 2020
27. Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J. Genetics, prevalence, screening and confirmation of primary aldosteronism: A position statement and consensus of the working group on endocrine hypertension of the european society of hypertension.J Hypertens. 2020
28. Pappaccogli M, Di Monaco S, Warchol-Celinska E, Lorthioir A, Amar L, Aparicio LS, Beauloye C, Bruno RM, Chenu P, de Leeuw P, De Backer T, Delmotte P, Dika Z, Gordin D, Heuten H, Iwashima Y, Krzesinski JM, Kroon AA, Mazzolai L, Poch E, Sarafidis P, Seinturier C, Spiering W, Toubiana L, Van der Niepen P, van Twist D, Visona A, Wautrecht JC, Witowicz H, Xu J, Prejbisz A, Januszewicz A, Azizi M, Persu A, European/International FMDR, Initiative, the Working Group H, the Kidney » of the European Society of H. The european/international fibromuscular dysplasia registry and initiative (feiri)- clinical phenotypes and their predictors based on a cohort of one thousand patients.Cardiovasc Res. 2020
29. Pieragostini R, Perrin G, Nevoret C, Amar L, Jannot AS, Sabatier P, Korb-Savoldelli V, Sabatier B. Conditional prescriptions of oral antihypertensive drugs for the management of hypertension urgencies in the inpatient setting: An observational study.J Clin Pharm Ther. 2020;45:282-289
30. Postel-Vinay N, Blanc FX, Steichen O, Housset B, Clerson P, Eveillard P, Leroyer C, Roche N. [pneumo-quest: A standardised self-questionnaire to be completed at home before a first appointment at a respiratory clinic].Rev Mal Respir. 2020;37:776-782
31. Postel-Vinay N, Steichen O, Pebelier E, Persu A, Berra E, Bobrie G, Savard S, Nogueria J, Azizi M. Home blood pressure monitoring and e-health: Investigation of patients’ experience with the hy-result system.Blood Press Monit. 2020;25:155-161
32. Redheuil A, Blanchard A, Pereira H, Raissouni Z, Lorthioir A, Soulat G, Vargas-Poussou R, Amar L, Paul JL, Helley D, Azizi M, Kachenoura N, Mousseaux E. Aldosterone-related myocardial extracellular matrix expansion in hypertension in humans: A proof-of-concept study by cardiac magnetic resonance.JACC Cardiovasc Imaging. 2020;13:2149-2159
33. Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultzekool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller P, Yang J, Nian Chee NY, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Chang CC, Wu VC, Somloova Z, Maiolino G, Barbiero G, Battistel M, Lenzini L, Quaia E, Pessina AC, Rossi GP. Subtyping of primary aldosteronism in the avis-2 study: Assessment of selectivity and lateralization.J Clin Endocrinol Metab. 2020;105
34. Saie C, Buffet A, Abeillon J, Drui D, Leboulleux S, Bertherat J, Zenaty D, Storey C, Borson-Chazot F, Burnichon N, Vincent M, Favier J, Baudin E, Giraud S, Gimenez-Roqueplo AP, Amar L, Lussey-Lepoutre C. Screening of a large cohort of asymptomatic sdhx mutation carriers in routine practice.J Clin Endocrinol Metab. 2020
35. Vantyghem MC, Azizi M, Chabre O, Rodien P, Salem JE, Touraine P, Chanson P. Editorial: Travelling in time and space in the heart of paris.Ann Endocrinol (Paris). 2020
36. Verweij P, Danaietash P, Flamion B, Menard J, Bellet M. Randomized dose-response study of the new dual endothelin receptor antagonist aprocitentan in hypertension.Hypertension. 2020;75:956-965